These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam)]. Minei-Rachmilewitz T. Harefuah; 1999 Jul; 137(1-2):25-7, 87. PubMed ID: 10959270 [Abstract] [Full Text] [Related]
3. Suicide by skull stab wounds: a case of drug-induced psychosis. Jousset N, Rougé-Maillart C, Turcant A, Guilleux M, Le Bouil A, Tracqui A. Am J Forensic Med Pathol; 2010 Dec; 31(4):378-81. PubMed ID: 21119328 [Abstract] [Full Text] [Related]
7. Paranoid psychosis related to mefloquine antimalarial prophylaxis. Fuller SJ, Naraqi S, Gilessi G. P N G Med J; 2002 Dec; 45(3-4):219-21. PubMed ID: 12968793 [Abstract] [Full Text] [Related]
8. [Psychopathological phenomena in long-term follow-up of acute psychosis after preventive mefloquinine (Lariam) administration]. Meszaros K, Kasper S. Nervenarzt; 1996 May; 67(5):404-6. PubMed ID: 9005352 [Abstract] [Full Text] [Related]
9. Hallucinations and persecutory delusions in mefloquine-associated suicide. Nevin RL. Am J Forensic Med Pathol; 2012 Jun; 33(2):e8. PubMed ID: 22104331 [No Abstract] [Full Text] [Related]
10. Childhood mefloquine-induced mania and psychosis: a case report. Thapa R, Biswas B. J Child Neurol; 2009 Aug; 24(8):1008-9. PubMed ID: 19295181 [Abstract] [Full Text] [Related]
11. Mefloquine and malaria prophylaxis. Drug Ther Bull; 1998 Mar; 36(3):20-2. PubMed ID: 9684417 [Abstract] [Full Text] [Related]
12. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine. Clattenburg RN, Donnelly CL. J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1606-8. PubMed ID: 9394947 [Abstract] [Full Text] [Related]
14. Drugs for preventing malaria in travellers. Jacquerioz FA, Croft AM. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006491. PubMed ID: 19821371 [Abstract] [Full Text] [Related]
15. Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine. Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL, Breman JG. Am J Trop Med Hyg; 1996 Oct 07; 55(1 Suppl):50-6. PubMed ID: 8702037 [Abstract] [Full Text] [Related]
16. [Neuropsychiatric symptoms caused by mefloquine (report of several cases)]. Murai Z, Baran B, Tolna J, Szily E, Gazdag G. Orv Hetil; 2005 Jan 16; 146(3):133-6. PubMed ID: 15693445 [Abstract] [Full Text] [Related]
17. Acute psychosis after mefloquine. Report of six cases. Sowunmi A, Adio RA, Oduola AM, Ogundahunsi OA, Salako LA. Trop Geogr Med; 1995 Jan 16; 47(4):179-80. PubMed ID: 8560592 [Abstract] [Full Text] [Related]
20. Mefloquine-induced grand mal seizure in tubercular meningitis. Bregani ER, Tien TV, Figini G. Panminerva Med; 1998 Dec 16; 40(4):345-6. PubMed ID: 9973835 [Abstract] [Full Text] [Related] Page: [Next] [New Search]